Iris HECHT,Joseph R. PODOJIL,Stephen D. MILLER,Eyal NERIA,Galit ROTMAN
申请号：
US15506770
公开号：
US20170275344A1
申请日:
2015.08.26
申请国别(地区):
US
年份:
2017
代理人:
摘要：
This invention, in at least some embodiments, relates to a protein C1ORF32 and its variants and fragments and fusion proteins thereof, and methods of use thereof for immunotherapy, and drug development, including but not limited to as immune modulators and for immune therapy, including for autoimmune disorders.
